A NEW MEDICAL study carried out in the US has revealed that daily aspirin usage is associated with slightly lower cancer mortality.
Researchers working with the National Cancer Society in the US said that they examined the association between daily aspirin use and overall cancer mortality in over 100,000 test cases with no history of cancer.
This new evidence suggests that research published in March 2012 which suggested that taking an aspirin a day significantly reduced the risk of developing cancer may not have been accurate. That research had found that daily aspirin use for five years could reduce the risk of cancer by 37 per cent.
These new findings demonstrated a 16 per cent lower risk of cancer in those who had taken aspirin every day for five years.
Between 1997 and 2008, 5138 of participants died from cancer. The study ultimately found that usage of aspirin on a daily basis correlated with slightly lower cancer mortality.
Researchers did say that while the findings are encouraging, it is too early to recommend that people start taking aspirin specifically to prevent cancer. Anybody considering starting a course of aspirin should consult a pharmacist or GP first.
To embed this post, copy the code below on your site
have your say